Obsc Perfection has won a confirmed work order worth Rs 31.4 crore from an India-based auto components manufacturer. The contract covers the manufacturing and supply of machined components under the DaVinci DCx program, with deliveries scheduled to continue until 2032.

What Happened

Obsc Perfection received a confirmed purchase order valued at Rs 31.4 crore from an India-based auto components manufacturer. The scope involves manufacturing and supplying machined components for the DaVinci DCx program, with a delivery timeline extending until 2032.

Order In Financial Context

The Rs 31.4 crore order is substantial relative to the company's recent financial scale, though the trailing twelve-month (TTM) revenue is reported as Rs 0.0 crore, making standard book-to-bill calculations technically infinite or undefined. The total disclosed order book, which sums the orders from the last three fiscal quarters shown below, now includes this significant addition alongside previous smaller wins. This filing marks a shift from smaller export nominations to a larger domestic manufacturing contract, potentially altering the revenue mix if executed efficiently.

Company Order Track Record

Order inflow velocity appears to be accelerating significantly with this single large order compared to the modest Rs 11.80 crore recorded in Q1FY27. The current order value of Rs 31.4 crore is notably larger than the typical per-order size visible in recent history, which included a Rs 1.2 crore and a Rs 10.6 crore win.

Execution And Revenue Quality

The consolidated financial data presents a stark contrast between order wins and realized revenue. For the latest available periods, revenue and net profit are reported at Rs 0.0 crore, with an operating profit margin (OPM) of 0.0%. This indicates that while the company is securing contracts, there is currently no visible revenue conversion in the audited figures, signaling either a long lead time for these specific projects or a reporting lag.

Revenue Growth - Order Wins Translating To Revenue

As Obsc Perfection has accelerated order wins, with a significant jump in Q1FY27 inflows, its annual standalone revenue has grown from Rs 0.0 crore in FY22 to Rs 0.0 crore in FY25 based on the provided consolidated data. However, standalone revenue growth rates show a positive trend of +25.1% in FY25, +19.8% in FY24, and +70.8% in FY23, suggesting underlying business expansion despite the consolidated reporting zeros.

Working Capital And Execution Capacity

Balance sheet and cashflow data are not explicitly provided in the input for detailed liquidity analysis. However, the absence of negative operating cashflow flags suggests no immediate distress signal in the available metrics. Monitoring whether the working capital cycle can support the ramp-up required for the DaVinci DCx program is essential, especially given the long duration until 2032.

What To Watch

• Execution rate: Monitor quarterly revenue run-rate vs total backlog. The transition from zero reported revenue to positive cash flow will be the critical validation of this order.
• OPM trajectory: Watch for margin quality as the DaVinci DCx contracts execute. Current OPM is 0.0%, so any positive realization will be a key metric.
• Client concentration: Assess what percentage of the disclosed order book comes from this new India-based client versus previous international entities.
• Timeline adherence: The contract extends to 2032; early delivery milestones will indicate operational capacity.

Key Observations

• Valuation check (as of 01 Sep 2026): P/E of 71.5x against ROCE of 19.01%. At the time of this article, valuation was pricing in execution improvement not yet visible in return ratios. (P/E is price-derived and will change; ROCE is from audited financials)
• Revenue gap: Consolidated TTM revenue is Rs 0.0 crore. This disconnect between order inflow and recognized revenue requires close scrutiny of the company's revenue recognition policies and project commencement dates.

OBSC Perfection reported a net profit of ₹105.10 crore for the half year ended September 30, 2025, reflecting a 32% increase compared to the same period in the previous year. Revenue from operations rose 31% to ₹886.43 crore, driven by higher income from operations which stood at ₹886.43 crore. The company's earnings per share (EPS) improved to ₹4.30 from ₹4.07 in the corresponding period of the prior year.

Financial Performance

The company's total income for the period reached ₹903.37 crore, up from ₹684.08 crore in the half year ended September 30, 2024. Expenditure increased to ₹775.59 crore from ₹575.29 crore, primarily due to higher consumption and manufacturing expenses which totaled ₹558.12 crore. Finance costs for the period were ₹15.73 crore, while depreciation and amortization amounted to ₹32.01 crore.

Balance Sheet Highlights

As of September 30, 2025, the company's shareholder funds stood at ₹1,145.00 crore, comprising share capital of ₹244.52 crore and reserves and surplus of ₹900.48 crore. Total assets were reported at ₹1,788.05 crore, with non-current assets of ₹885.54 crore and current assets of ₹903.66 crore. The company's cash and cash equivalents decreased to ₹89.98 crore from ₹166.00 crore as of March 31, 2025.

Cash Flow Statement

Cash flow from operating activities was negative at ₹36.54 crore, compared to a positive ₹46.98 crore in the previous year. Cash used in investing activities was ₹173.54 crore, primarily due to purchases of fixed assets amounting to ₹175.26 crore. Financing activities provided a cash inflow of ₹134.06 crore, driven by an increase in borrowings of ₹149.80 crore.

Auditor's Report

P. K. Chand & Co., Chartered Accountants, issued a limited review report with an unmodified opinion on the unaudited financial results for the half year ended September 30, 2025. The report confirmed that the financial statements comply with the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Utilization of Issue Proceeds

The statutory auditors certified the utilization of net proceeds from the issue of shares. Out of the total disclosed amount of ₹580.00 crore, ₹470.89 crore had been utilized as of September 30, 2025. The unutilized amount of ₹109.11 crore is allocated for funding capital expenditure requirements towards the purchase of machinery for the company's existing manufacturing facility in Chennai, Tamil Nadu.